TrialJournal of cancer research and clinical oncology2023
A randomized, open-label, two-cycle, two-crossover phase I clinical trial comparing the bioequivalence and safety of afatinib and Giotrif
Guangwen Liu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.